Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Edwards Lifesciences

Stocks With Rising Relative Strength: Edwards Lifesciences

Edwards Lifesciences shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance

Edwards Lifesciences’ (NYSE:EW) stock surged Friday following a strong second-quarter 2025 earnings report that saw the medical device innovator surpass revenue and earnings expectations, driven by significant growth across its heart valve therapies.

Benzinga

Stock Market Today: Dow, S&P Climb On Trump-China Deal Hopes; Cathie Wood Loads Up On Tesla Stock (Live Coverage)

The Dow Jones index rose after surprise economic data. Tesla stock rallied on new plans to launch its robotaxi service.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

How Boston Scientific's Loss Was Edwards Lifesciences' Gain In the Second Quarter

Edwards Lifesciences stock surged Friday after the medtech hiked its outlook following a key setback for rival Boston Scientific.

Investors Business Daily

Is Edwards Lifesciences Stock Underperforming the Dow?

Despite Edwards Lifesciences’ underperformance relative to the broader Dow over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Edwards Lifesciences Sees IBD RS Rating Rise To 71

Edwards Lifesciences shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Edwards Lifesciences Getting Closer To Key Technical Measure

A Relative Strength Rating upgrade for Edwards Lifesciences shows improving technical performance. Will it continue?

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

How Boston Scientific's Surprise Setback Bolstered Two Of Its Top Rivals

Edwards Lifesciences stock jumped Wednesday after Boston Scientific said it would stop selling its rival heart-valve replacement systems.

Investors Business Daily

Do Wall Street Analysts Like Edwards Lifesciences Stock?

Despite Edwards Lifesciences’ underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

Edwards Shoots Higher As It Shrugs Off Tariffs Worries — Until 2026

Edwards stock shot higher Thursday after the medtech player said tariffs are likely to have little impact in 2025.

Investors Business Daily

Edwards Makes A Bullish Move As Heart-Valve Replacements Top $1 Billion

Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.

Investors Business Daily

Is Edwards Lifesciences Stock Underperforming the S&P 500?

Edwards Lifesciences has recently underperformed the broader S&P 500, yet analysts remain moderately optimistic about the stock's potential.

Barchart

The Analyst Verdict: Edwards Lifesciences In The Eyes Of 17 Experts

Analysts' ratings for Edwards Lifesciences (NYSE:EW) over the last quarter vary from bullish to bearish, as provided by 17 analysts.

Benzinga

Edwards Skids On Weak Expectations For Its Bread-And-Butter Moneymaker

Edwards Lifesciences stock fell Friday after the company said its TAVR segment will face numerous challenges in the fourth quarter.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

How Is Edwards Lifesciences' Stock Performance Compared to Other Medical Devices Stocks?

While Edwards Lifesciences has underperformed the broader medical devices industry recently, analysts are moderately bullish on the stock's prospects.

Barchart

Is Wall Street Bullish or Bearish on Edwards Lifesciences Stock?

Despite Edwards Lifesciences’ underperformance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Investors Business Daily

Edwards Crashes 31% After Slashing Guidance For Its Biggest Moneymaker

Edwards Lifesciences stock plummeted Thursday after the medtech cut its outlook for TAVR sales following a mixed second-quarter report.

Barchart

What You Need to Know Ahead of Edwards Lifesciences' Earnings Release

Edwards Lifesciences is expected to release its second-quarter earnings this month, and analysts expect a single-digit profit increase.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Edwards Lifesciences Trying To Close In On Key Technical Measure

Edwards Lifesciences shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Barchart

Edwards Lifesciences Stock: Is EW Underperforming the Healthcare Sector?

Edwards Lifesciences has recently underperformed the Healthcare sector, but Wall Street analysts anticipate a modest upside for the stock.

Investors Business Daily

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal

Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion.

Investors Business Daily

This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss

Edwards Lifesciences stock underperformed its peers on Friday, sliding on light sales of its transcatheter aortic heart-valve replacements.

The Guardian - UK

Medical device companies pay millions to NHS while pushing products, says study

Pharmaceutical equipment firms are funding NHS staff and training while promoting sales

Investors Business Daily

Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark

Edwards Lifesciences sees its Relative Strength Rating hit the 80-plus level.

Investors Business Daily

Edwards Lifesciences' Fortunes Are Reaccelerating, Analyst Says — But Its Stock Isn't

There are signs Edwards' heart valve replacement technology is reaccelerating, an analyst said Wednesday. But EW stock only inched ahead.

1 2 3

People

Jonathan Evans

24 stories

Margaret Kaczor Andrew

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.